Top broker sees 19% upside in the Cochlear (ASX:COH) share price

Are Cochlear's shares in the buy zone?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Cochlear Limited (ASX: COH) share price has been a poor performer in recent weeks.

Since hitting a record high of $257.76 in mid-August, the hearing solutions company's shares have fallen 17% to $214.85.

Why is the Cochlear share price falling?

A good portion of the decline in the Cochlear share price has come in recent weeks after the company made an announcement.

That announcement revealed that a complaint for patent infringement has been filed by the University of Pittsburgh in the United States District Court for the Western District of Texas, Waco division.

The release reveals that the patent in question is related to a wireless energy transfer system. It was filed at the US Patent Office in 2009 and will expire in 2030.

However, management does not believe that its products infringe the University's patent and will defend the lawsuit.

It highlights that Cochlear's legacy products and related patents predate the University's patent by several years. Furthermore, these earlier legacy products and patents embody the alleged invention of the patent and, accordingly, Cochlear believes the patent is invalid.

Is this a buying opportunity?

One leading broker that is likely to see the weakness in the Cochlear share price as a buying opportunity is Macquarie Group Ltd (ASX: MQG).

According to a recent note, the broker has an outperform rating and $256.00 price target on the company's shares. Based on the current Cochlear share price, this implies potential upside of 19% over the next 12 months.

And while Macquarie has not commented on the patent dispute, it is worth noting that another broker has and isn't concerned.

Last week Citi said that it expects the case to be immaterial to Cochlear. This is due to the company's own wireless energy transfer patents predating those of the University of Pittsburgh.

In addition, the broker doesn't expect the news to disrupt Cochlear's existing and future business in a meaningful way.

Citi currently has a hold rating and $220.00 price target on the Cochlear share price.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Cochlear Ltd. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool Australia has recommended Cochlear Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Opinions

2 ASX shares I have been buying in 2024!

I’m a believer in the long-term outlook of these stocks.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »